ResearcherMario Negri Institute for Pharmacological ResearchNo recent work listed
Luca Porcu
Matched on ORCID iD 0000-0002-0911-9775; OpenAlex author ID A5004127829, A5066152196. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers
Papers 4
- Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer. Last author DOI 10.1001/jamaoncol.2022.7358↗
- Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary a… Co-author DOI 10.1016/j.esmoop.2022.100777↗
- Soluble stroma-related biomarkers of pancreatic cancer. Co-author DOI 10.15252/emmm.201708741↗
- Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma. Co-author DOI 10.1007/s00280-015-2932-3↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michele Reni · 2 shared papers, 2016–2023 · strength 0.36
- Marina Macchini · 1 shared paper, 2023 · strength 0.31
- Paola Allavena · 2 shared papers, 2016–2018 · strength 0.12
- Andrea Resovi · 1 shared paper, 2018 · strength 0.07
- Alessia Anastasia · 1 shared paper, 2018 · strength 0.07
- Dorina Belotti · 1 shared paper, 2018 · strength 0.07
- Paola Cappello · 1 shared paper, 2018 · strength 0.07
- Francesco Novelli · 1 shared paper, 2018 · strength 0.07
- Aldo Scarpa Scarpa · 1 shared paper, 2018 · strength 0.07
- Raffaella Giavazzi · 1 shared paper, 2018 · strength 0.07
- Carmen Belli · 1 shared paper, 2016 · strength 0.05
- Claudio Doglioni · 1 shared paper, 2016 · strength 0.05
- Erica Dugnani · 1 shared paper, 2016 · strength 0.05
- Maria Giulia Cangi · 1 shared paper, 2016 · strength 0.05
- Lorenzo Piemonti · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.